Tolerance to weekly doses of 2-amino-6-[(1-methyl-4-nitro-5-imidazolyl)thio]-purine (B.W. 57-323) in humans.

O. S. SELAWRY, J. F. HOLLAND

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)53-55
Number of pages3
JournalCancer chemotherapy reports. Part 1
Volume8
StatePublished - Jul 1960

Cite this